Impact of HER2 Expression on the Prognosis of Muscle-Invasive Bladder Cancer Patients Treated with Bladder-Preservation Comprehensive Therapy

Abstract Background HER2 expression has been confirmed to be associated with bladder cancer aggressiveness. Anti-HER2 RC48-ADC is approved in China for the treatment of patients with advanced urothelial carcinoma with failed chemotherapy who are HER2 positive (IHC 2 + or 3 +). The discovery of HER2...

Full description

Saved in:
Bibliographic Details
Main Authors: Yatong Chen, Fei Luo, Tingji Zhang, Jian Li
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Biological Procedures Online
Subjects:
Online Access:https://doi.org/10.1186/s12575-025-00261-w
Tags: Add Tag
No Tags, Be the first to tag this record!